← HB3057 bill details

Substantive final action

HB3057

Read 3rd time

Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.

Failed Senate May 27, 2025⭐ Substantive final action

0Yea
1Nay
0Not voting
0Absent

Nay (1)

Source provenance